id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
NRC-2008-0175-0094,NRC,NRC-2008-0175,"Guidance for Final Rule ""Medical Use of Byproduct Material - Medical Event Definitions, Training and Experience, and Clarifying Amendments""",Other,,2018-07-16T00:00:00Z,2018,7,2018-07-16T00:00:00Z,,2025-05-21T07:08:58Z,,0,0,0900006483502d55
NRC-2008-0175-0070,NRC,NRC-2008-0175,"Summary of February 12, 2015, Public Meeting Between Spectrum Pharmaceuticals, Inc., and the NRC Regarding Modification of the Training and Experience Requirements for  Beta Emitter Products",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:01Z,,0,0,0900006481a3b31d
NRC-2008-0175-0068,NRC,NRC-2008-0175,"Summary of October 8, 2014, Meeting",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:02Z,,0,0,0900006481a3b725
NRC-2008-0175-0069,NRC,NRC-2008-0175,"Transcript of October 8, 2014, Meeting",Other,,2015-03-11T00:00:00Z,2015,3,2015-03-11T00:00:00Z,,2025-05-21T07:30:02Z,,0,0,0900006481a3b726
NRC-2008-0175-0018,NRC,NRC-2008-0175,"Draft Regulatory Analysis for Proposed Rule:  Amendments to Medical Use of Byproduct Material Regulations (10 CFR Parts 30, 32, and 35)",Other,,2014-07-23T00:00:00Z,2014,7,2014-07-23T00:00:00Z,,2025-05-21T07:31:14Z,,0,0,09000064817d8091
NRC-2008-0175-0019,NRC,NRC-2008-0175,"Draft Environmental Assessment and Finding of No Significant Impact for the Proposed Rule Amending 10 CFR Parts 30, 32, and 35 - Medical Use of Byproduct Material:  Medical Event Definitions, Training and Experience, and Clarifying Amendments",Other,,2014-07-23T00:00:00Z,2014,7,2014-07-23T00:00:00Z,,2025-05-21T07:31:14Z,,0,0,09000064817d8092
NRC-2008-0175-0004,NRC,NRC-2008-0175,Part 35 Preliminaray Draft Proposed Rule Language,Other,,2011-05-20T00:00:00Z,2011,5,2011-05-20T00:00:00Z,2011-09-16T03:59:59Z,2025-05-21T08:52:31Z,,0,0,0900006480dbbacc